Physics of medical imaging courses
Programme description
This series of courses is organised by the Joint Department of Physics of The Royal Marsden NHS Foundation Trust and The Institute of Cancer Research, London.
The courses provide the necessary physics background that underpins day-to-day medical imaging physics activities. They are aimed primarily at new entrants to the profession, but should be of benefit to postgraduate students, postdoctoral research workers, physicist-managers, representatives of allied commercial organisations and anyone wishing to deepen or re-establish their understanding of the physics of medical imaging.
The faculty is composed mainly of physicists, many of whom are internationally renowned for their expertise. A selection of key talks delivered by clinicians and other scientists provide the broader scientific and clinical perspective. Overviews of specialised or research related topics, such as MR Spectroscopy are given.
There are opportunities for informal discussions, and there may be chances to visit imaging modalities of The Royal Marsden NHS Foundation Trust and/or the research labs of The Institute of Cancer Research. There will be a visit to the MR Units as part of the MRI & Spectroscopy course.
The programme consists of five separate courses. Each course is repeated annually.
All courses in the series are CPD courses approved by IPEM.
Course details
Course 1: MRI & Spectroscopy
Course dates: Monday 12th - Wednesday 14th October 2026
Closing date for completed registrations: Monday 28th September 2026
Venue: Sutton campus
Course 1 - Provisional timetable 2026
Course 2 - More information / Register
Course Organiser: Dr Simon Doran
For registration details and any other queries contact:
Course Administrator: Mrs Melisa Porter
Course 2: Ultrasound Imaging
Course dates: Tuesday 10th - Thursday 12th November 2026
Closing date for completed registrations: Friday 23rd October 2026
Venue: Sutton campus
Course 2 - Provisional Lecture Synopses
Course 2 - More information / Register
Course Organiser: Mr Mark O’Leary
Course Administrator: Mrs Jessica Keegan
Tel: +44 (0)20 8661 3075
Course 3: Image Theory, Perception and Machine Learning
Course dates: Monday 8th - Tuesday 9th February 2027
Closing date for completed registrations: Friday 22nd January 2027
Venue: Chelsea campus
Course 3 - Provisional Lecture Synopses
Course 3 - More information / Register
Course Organiser: Dr Jamie Dormand
Tel: +44 (0)20 7808 2514
Course Administrator: Mrs Jessica Keegan
Tel: +44 (0)20 8661 3075
Course 4: Diagnostic Radiology and CT
Course dates: Wednesday 10th - Friday 12th February 2027
Closing date for completed registrations: Friday 22nd January 2027
Venue: Chelsea campus
Course 4 - Provisional Lecture Synopses
Course 4 - More information / Register
Course Organiser: Dr Jamie Dormand
Tel: +44 (0)20 7808 2514
Course Administrator: Mrs Jessica Keegan
Tel: +44 (0)20 8661 3075
Course 5: Nuclear Medicine
Course dates: Tuesday 9th - Friday 12th March 2027
Closing date for completed registrations: Friday 19th February 2027
Venue: Sutton campus
Course 5 - Provisional Lecture Synopses
Course 5 - More information / Register
Course Organiser: Dr Iain Murray
Tel: +44 (0)20 8661 3715
Course Administrator: Mrs Jessica Keegan
Tel: +44 (0)20 8661 3075
Course fees
Prices GBP | Course 1 | Course 2 | Course 3 | Course 4* | Course 5* |
Standard price | £640 | £645 | £325 | £645 | £860 |
University and Hospital Staff and all trainees | £510 | £525 | £265 | £525 | £700 |
Full time students | £280 | £285 | £145 | £285 | £380 |
*One or two day registration on Courses 4 and 5 is accepted and will be charged pro rata. Please contact the course administrator for details.
Course fees include lunches and light refreshments.
Please check each course for the registration closing date.
Venue
Courses 1, 2 and 5 are held on the Sutton campus of the Institute of Cancer Research. Courses 3 and 4 are held on the Chelsea campus.
Travel information for the ICR campus
Latest ICR News
Targeting cancer cell DNA repair mechanism may make radiotherapy more effective
ICR welcomes FDA approval of capivasertib for advanced prostate cancer
Thousands of men with prostate cancer will now be offered high-powered radiotherapy on the NHS